Simon N. Pimstone, Director at Xenon Pharmaceuticals Inc. (XENE), sold 78,326 shares at $30.66 ($2.3M) on 2022-03-04, disclosed to the SEC on 2022-03-08.
Open-market sale of $2.3M XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.56 | 4,793 | $146K | 6.3% |
| 2 | $30.56 | 4,793 | $146K | 6.3% |
| 3 | $30.66 | 4,532 | $139K | 6.0% |
| 4 | $30.66 | 4,532 | $139K | 6.0% |
| 5 | $31.42 | 963 | $30K | 1.3% |
| 6 | $30.23 | 1,990 |
| $60K |
| 2.6% |
| 7 | $30.44 | 4,516 | $137K | 5.9% |
| 8 | $30.44 | 4,516 | $137K | 5.9% |
| 9 | $30.45 | 4,516 | $138K | 5.9% |
| 10 | $30.45 | 4,516 | $138K | 5.9% |
| 11 | $30.49 | 4,517 | $138K | 5.9% |
| 12 | $30.49 | 4,517 | $138K | 5.9% |
| 13 | $30.50 | 7,500 | $229K | 9.8% |
| 14 | $30.52 | 2,500 | $76K | 3.3% |
| 15 | $30.55 | 2,500 | $76K | 3.3% |
| 16 | $30.60 | 5,037 | $154K | 6.6% |
| 17 | $30.60 | 5,037 | $154K | 6.6% |
| 18 | $3.80 | 2,500 | $10K | 0.4% |
| 19 | $30.55 | 2,500 | $76K | 3.3% |
| 20 | $30.60 | 2,051 | $63K | 2.7% |
| Total | $29.68 avg | 78,326 | $2.3M | 100% |
| Filing → |
| XENE | SELL | 2022-08-16 | $10.9M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |
| XENE | SELL | 2021-11-16 | $1.1M | — | Filing → |